Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Peter Gray to retire, succeeded by CFO Ciaran Murray
September 7, 2011
By: Gil Roth
Peter Gray will step down as chief executive officer of ICON PLC, after 14 years with the company, including nine in his current role. The board has appointed Ciaran Murray, who has held the position of chief financial officer for the past 6 years, to succeed Mr. Gray, effective October 1, 2011. Mr. Murray has also been appointed as a member of the board. Mr. Gray has agreed to take on the role of vice chairman to facilitate a smooth transition and to assist the board in continuing strategic development. Dr. Bruce Given, ICON’s chairman, commented, “Peter’s leadership has been fundamental in establishing ICON as an industry leading company and creating a world-class management team. His contribution to ICON’s growth and to its success cannot be overstated.” Dr. Given added that Mr. Murray “brings a deep knowledge of the industry together with extensive operational and global experience,” and “has been a key member of the management team through ICON’s transformation to a global leader.” “It has been a great honor to lead ICON through an extremely exciting phase of its development” said Mr. Gray. “At a time of unprecedented change in the industry, ICON is well positioned to capitalize on the investments we have been making in recent years and I believe that Ciaran is the right person to lead the organization and its outstanding people through this next phase of growth.” Following Mr. Murray’s appointment, Brendan Brennan, currently senior vice president of Corporate Finance, will be appointed acting CFO, and Diarmaid Cunningham, general counsel, will take on the additional role of company secretary.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !